# Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer

> **NCT02102438** · NA · WITHDRAWN · sponsor: **Instituto do Cancer do Estado de São Paulo**

## Conditions studied

- Breast Cancer
- HER-2 Positive Breast Cancer

## Interventions

- **DRUG:** Trastuzumab
- **DRUG:** Weekly Paclitaxel
- **DRUG:** Carboplatin

## Key facts

- **NCT ID:** NCT02102438
- **Lead sponsor:** Instituto do Cancer do Estado de São Paulo
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2014-04
- **Primary completion:** 2016-04
- **Final completion:** 2018-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** No financial support aproved
- **Last updated:** 2016-08-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02102438

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02102438, "Chemotherapy for Elderly Patients Diagnosed With Localized HER2 Positive Breast Cancer". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT02102438. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*